EC18, a representative HCN4-preferring blocker, significantly reduced network excitability and epileptogenicity in a PTZ-induced convulsion model in wild-type mice, but had no effect in Hcn4 conditional knockout mice—this strongly supports its antiepileptic mechanism via targeting HCN4 channels (88). Here, HCN4 is linked to convulsion.